# Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery

> **NCT01221116** · NA · TERMINATED · sponsor: **Ullevaal University Hospital** · enrollment: 23 (actual)

## Conditions studied

- Heart Failure
- Cardiac Surgery

## Interventions

- **DRUG:** levosimendan

## Key facts

- **NCT ID:** NCT01221116
- **Lead sponsor:** Ullevaal University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-01
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** The study was stopped due to difficulties in including patients
- **Last updated:** 2010-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01221116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01221116, "Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01221116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*